Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

Source:http://linkedlifedata.com/resource/pubmed/id/17595355

Download in:

View as

General Info

PMID
17595355